Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function.
Stanley M H YeungS Heleen BinnenmarsChristina M GantGerjan NavisRon T GansevoortStephan J L BakkerMartin H de BorstGozewijn D LavermanPublished in: Diabetes care (2019)
In patients with type 2 diabetes and normal or mildly impaired kidney function, FGF23 is associated with an increased risk of cardiovascular events and mortality.